Abstract
Microarray patches (MAPs) have been employed to deliver therapeutic payloads and for detection purposes. Research has been conducted to develop novel designs in material chemistry and the architecture of microarray, which have opened up the possibility for broader applications of MAPs. However, MAPs have yet to be clinically implemented fully. Addressing the current challenges and maximizing opportunities will pave the way to translate the relevant technologies from bench to bedside.
Original language | English |
---|---|
Pages (from-to) | 25-30 |
Number of pages | 6 |
Journal | New Biotechnology |
Volume | 86 |
Early online date | 14 Jan 2025 |
DOIs | |
Publication status | E-pub ahead of print - 14 Jan 2025 |
Funding
We thank the National Institutes of Health [RO1 AT009741 to T.S.M.] and the Office of Naval Research [N00014-24-1-2723] for the support. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency.
Funders | Funder number |
---|---|
National Institutes of Health | RO1 AT009741 |
Office of Naval Research | N00014-24-1-2723 |
Keywords
- Clinical translation
- Drug delivery
- Mass production
- Microarray patches
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Molecular Biology